Rapid Micro Biosystems (RPID) Stock Price
Rapid Micro Biosystems Price
Revenue has compounded at 5.0% per year over the past 15 years to 33.59 M USD. Rapid Micro Biosystems's net margin stands at -140.3%, up from -316.5% several years earlier.
Rapid Micro Biosystems stock price
Rapid Micro Biosystems business model & stock analysis
Frequently asked questions about Rapid Micro Biosystems
The business model of Rapid Micro Biosystems Inc is centered around providing innovative solutions for microbial quality control in the pharmaceutical and healthcare industries. The company offers automated microbial detection systems that enable faster and more efficient testing of samples, allowing pharmaceutical companies to streamline their processes and minimize the risk of contamination. Rapid Micro Biosystems Inc's technology helps customers improve product quality, reduce time-to-results, and increase operational efficiency. With its cutting-edge products and services, the company aims to revolutionize microbial testing and support the production of safe and high-quality pharmaceuticals.
Rapid Micro Biosystems Inc is primarily active in the pharmaceutical, biotechnology, and healthcare industries.
The main competitors of Rapid Micro Biosystems Inc in the market include Thermo Fisher Scientific Inc., BioMérieux SA, and Beckman Coulter Inc.
Rapid Micro Biosystems Inc is a renowned company specialized in innovative microbial detection and enumeration systems. Founded in 2006, Rapid Micro Biosystems has a rich history of developing cutting-edge technologies for the pharmaceutical, personal care, and clinical industries. The company focuses on automating and streamlining microbial quality testing processes, offering faster and more accurate results. With a wide range of solutions, including Growth Direct™, Rapid Micro Biosystems aids customers in improving their manufacturing efficiency, ensuring product safety, and minimizing risks associated with microbial contamination. Rapid Micro Biosystems Inc continues to revolutionize microbial detection, providing reliable and advanced solutions to various industries worldwide.
Rapid Micro Biosystems Inc has achieved several significant milestones. Firstly, the company successfully developed the Growth Direct™ System, a cutting-edge automated microbial detection platform used in pharmaceutical manufacturing. Additionally, Rapid Micro Biosystems Inc received strategic funding from top investors, allowing them to expand their operations and commercialize their products globally. They also gained regulatory approvals for their innovative technology, further establishing themselves as a leading player in the industry. Additionally, Rapid Micro Biosystems Inc has secured partnerships and collaborations with prominent pharmaceutical companies, strengthening their market position and facilitating growth. With these achievements, Rapid Micro Biosystems Inc continues to revolutionize microbial testing and make significant advancements in the field.
Rapid Micro Biosystems Inc is primarily present in the United States, alongside multiple international regions.
Rapid Micro Biosystems Inc represents values of innovation, efficiency, and reliability in the field of microbiology. With a strong corporate philosophy focused on advancing automation and streamlining processes, Rapid Micro Biosystems aims to transform the way microbiological testing is conducted. Their cutting-edge technologies and solutions enable faster and more accurate detection of microbial contaminants, helping industries ensure the safety and quality of their products. Through their commitment to providing reliable and efficient microbiology systems, Rapid Micro Biosystems Inc contributes to improved productivity, reduced costs, and enhanced product quality across various industries.
10 analysts currently rate the Rapid Micro Biosystems stock: 9 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Rapid Micro Biosystems to generate revenue of 39.28 M USD and earnings per share of -0.94 USD.
Converted at the current exchange rate, the Rapid Micro Biosystems share trades at 0.80 EUR (0.89 USD).
The Rapid Micro Biosystems share (RPID) is listed on 1 stock exchanges, including: NASDAQ (RPID).
Rapid Micro Biosystems Inc. specializes in the manufacturing of automated solutions for microbiological testing and production controls. The company operates in the biotechnology industry and offers a variety of products and services. One of the main products is the Growth DirectTM, an automated system for identifying, quantifying, and monitoring microorganisms in biopharmaceutical production processes. It is used by customers in the pharmaceutical and biotechnology industries to optimize production processes and perform quality controls. Another core product is the Growth DirectTM System for environmental monitoring. It provides a fast, easy, and reliable way to perform environmental controls throughout the manufacturing process. The company also offers services such as installation, training, maintenance, and support for its systems. Rapid Micro Biosystems has a strong presence in the global market and works with customers in Asia, Europe, and North America. Overall, the company focuses on developing solutions for managing microbiological tests and process monitoring in the biotechnology and pharmaceutical industries, aiming to provide customers with more efficient process optimization and error detection.
The expected revenue of Rapid Micro Biosystems is 39.28 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Rapid Micro Biosystems is -41.77 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Rapid Micro Biosystems is currently -0.95. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Rapid Micro Biosystems stock.
The price-to-sales ratio (P/S) of Rapid Micro Biosystems is currently 1.01. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Rapid Micro Biosystems stock.
The Eulerpool Quality Score for Rapid Micro Biosystems is 3/10.
The ISIN of Rapid Micro Biosystems is US75340L1044. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Rapid Micro Biosystems is RPID. The ticker symbol is used to trade Rapid Micro Biosystems shares on the stock exchange.
Rapid Micro Biosystems stock
Rapid Micro Biosystems Peer Group
Rapid Micro Biosystems Ticker
Rapid Micro Biosystems FIGI
All fundamentals and in-depth analysis of Rapid Micro Biosystems
Our stock analysis for Rapid Micro Biosystems stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Rapid Micro Biosystems. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.